Chemical industry – Page 103
-
Business
BMS sells OTC drugs for $482m
Bristol-Myers Squibb will offload rights to a range of over-the-counter products to Reckitt Benckiser
-
CareersToxicologist with pesticides on the brain
Vanessa Fitsanakis’ career in toxicology goes all the way back to the farm where she grew up. Helen Carmichael traces her journey from agriculture to academia
-
Business
Biogen buys Tysabri from Elan for $3.25bn
Elan earns huge cash injection for blockbuster drug
-
Business
GSK commits to AllTrials data disclosure
Company will begin publishing all clinical study reports
-
News
Small business office chemical industry pawn, watchdog claims
The US Small Business Administration’s little-known Office of Advocacy is accused of trying to dilute efforts to regulate certain chemicals
-
BusinessReach reviewed: no change required
But disproportionate cost of compliance for small and medium size companies should be reduced, European commission says
-
BusinessEU proposes neonicotinoid pesticide ban
Clothianidin, thiamethoxam and imidacloprid at centre of debate over declining bee populations
-
Business
Zoetis IPO launches at $2.2bn
Pfizer spin off will be a big player among a relatively small number of public companies focusing on animal heatlh
-
Business
DCD in New Zealand milk
Dicyandiamide poses no food risk but fertiliser companies have suspended sales
-
Business
Sabic invests $500m in new R&D centres
Four centres to be created: two in Saudi Arabia, one in India and one in China
-
BusinessUnrest over US gas exports
Dow says exports will increase cost of gas and decrease price stability
-
Business
Allergan buys MAP for $958m
Deal strengthens Allergan’s position in neurology with Levadex for treating migraine
-
OpinionName reactions: how does the label stick?
Derek Lowe investigates the long running tradition of naming reactions after their inventors
-
Business
Vasella to leave Novartis in August
Long serving chair of the board of directors will be succeeded by Jörg Reinhardt
-
Business
OM Group to exit cobalt business
Deal worth up to $435 million includes downstream activities, in particular cobalt refining in Kokkola, Finland
-
Business
Flu vaccine without the eggs approved
Flublok does not require flu virus or eggs for manufacture
-
BusinessIndia pushes for emergency drug licences
Government looks set to force licensing of three patented cancer drugs